InsidersTradesSigma
Discover the full record of transactions filed by Hallock Kenneth, Director. Director active across 1 companies, notably Greenwich LifeSciences, Inc.. In total, 2 reports have been recorded. Total volume traded: €9k. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Kenneth Hallock is a Director at Greenwich LifeSciences, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. With expertise in the life sciences field, he brings valuable insights to the board, contributing to the company's strategic direction.